{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:34:38Z","timestamp":1788244478607,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mucosal healing, confirmed by endoscopic evaluation, is the long-term goal of treatment for Crohn\u2019s disease (CD). Leucine-rich alpha-2 glycoprotein (LRG) is a new serum biomarker correlated with disease activity in inflammatory bowel disease. However, studies evaluating its relationship with CD, particularly in the context of small intestinal lesions, are scarce. The aim of this study was to investigate the accuracy of LRG in assessing endoscopic activity, especially remission, in patients with CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between July 2020 and March 2021, 72 patients with CD who underwent LRG testing and double-balloon endoscopy at the same time were included. Endoscopic activity was evaluated using the applied Simple Endoscopic Score for Crohn\u2019s disease, including small intestine lesions. The relationship of LRG with clinical symptoms and endoscopic activity was assessed, and its predictive accuracy was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Leucine-rich alpha-2 glycoprotein showed a significant positive correlation with endoscopic activity (r\u2005=\u20050.619, P &amp;lt; .001), even in patients with active lesions in the small intestine (r\u2005=\u20050.626, P &amp;lt; .001). Multivariate logistic regression revealed that LRG was the only factor associated with endoscopic remission. An LRG cutoff value of 8.9 \u03bcg\/mL had a sensitivity of 93.3%; specificity of 83.3%; positive predictive value of 96.6%; negative predictive value of 71.4%; accuracy of 91.7%; and area under the curve of 0.904 for the prediction of endoscopic remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Leucine-rich alpha-2 glycoprotein can be used in assessing endoscopic activity and is a reliable marker of endoscopic remission in CD patients. It can be an intermediate target in the treatment of CD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izac076","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:41:41Z","timestamp":1650285701000},"page":"245-253","source":"Crossref","is-referenced-by-count":36,"title":["Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn\u2019s Disease"],"prefix":"10.1093","volume":"29","author":[{"given":"Tatsuya","family":"Kawamura","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-016X","authenticated-orcid":false,"given":"Takeshi","family":"Yamamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, Nagoya University Hospital , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunaki","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, Nagoya University Hospital , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kakushima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizaburo","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, Nagoya University Hospital , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ishigami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , 65 Tsuruma-cho, Showa-ku, Nagoya 466 - 8550 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"2023020108373262500_CIT0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CEG.S41413","article-title":"Measuring disease activity in Crohn\u2019s disease: what is currently available to the clinician","volume":"7","author":"D\u2019Inc\u00e0","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"key":"2023020108373262500_CIT0002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gie.2005.08.011","article-title":"Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn\u2019s disease","volume":"63","author":"Rutgeerts","year":"2006","journal-title":"Gastrointest Endosc."},{"key":"2023020108373262500_CIT0003","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Fr\u00f8slie","year":"2007","journal-title":"Gastroenterology"},{"key":"2023020108373262500_CIT0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11894-013-0315-7","article-title":"Deep remission in inflammatory bowel disease: looking beyond symptoms","volume":"15","author":"Zallot","year":"2013","journal-title":"Curr Gastroenterol Rep."},{"key":"2023020108373262500_CIT0005","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ibd.21034","article-title":"Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn\u2019s disease","volume":"15","author":"D\u2019Haens","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2023020108373262500_CIT0006","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"2023020108373262500_CIT0007","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bpg.2016.09.005","article-title":"Complications of diagnostic colonoscopy, upper endoscopy, and enteroscopy","volume":"30","author":"Levy","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"2023020108373262500_CIT0008","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cgh.2012.03.026","article-title":"Endoscopic skipping of the distal terminal ileum in Crohn\u2019s disease can lead to negative results from ileocolonoscopy","volume":"10","author":"Samuel","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023020108373262500_CIT0009","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D\u2019Haens","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2023020108373262500_CIT0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MIB.0b013e3182810066","article-title":"Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes","volume":"19","author":"Schoepfer","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2023020108373262500_CIT0011","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ibd.21136","article-title":"Fecal calprotectin variability in Crohn\u2019s disease","volume":"16","author":"Moum","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"2023020108373262500_CIT0012","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1258\/acb.2009.009061","article-title":"Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers","volume":"47","author":"Joshi","year":"2010","journal-title":"Ann Clin Biochem."},{"key":"2023020108373262500_CIT0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/biomedicines8070193","article-title":"The new proactive approach and precision medicine in Crohn\u2019s disease","volume":"8","author":"Zittan","year":"2020","journal-title":"Biomedicines"},{"key":"2023020108373262500_CIT0014","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2050640616686517","article-title":"Compliance with the faecal calprotectin test in patients with inflammatory bowel disease","volume":"5","author":"Mar\u00e9chal","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"2023020108373262500_CIT0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17550","article-title":"Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation","volume":"17","author":"Waugh","year":"2013","journal-title":"Health Technol Assess."},{"key":"2023020108373262500_CIT0016","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/diagnostics10060367","article-title":"Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults","volume":"10","author":"Krzystek-Korpacka","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2023020108373262500_CIT0017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1515\/bchm2.1977.358.1.639","article-title":"Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author\u2019s translation).","volume":"358","author":"Haupt","year":"1977","journal-title":"Hoppe-Seylers Z Physiol Chem."},{"key":"2023020108373262500_CIT0018","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.118919","article-title":"iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases","volume":"69","author":"Serada","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"2023020108373262500_CIT0019","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1038\/s41598-020-60450-3","article-title":"Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis","volume":"10","author":"Fujimoto","year":"2020","journal-title":"Sci Rep."},{"key":"2023020108373262500_CIT0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clinbiochem.2017.02.010","article-title":"Circulating human leucine-rich \u03b1-2-glycoprotein 1 mRNA and protein levels to detect acute appendicitis in patients with acute abdominal pain","volume":"50","author":"Rainer","year":"2017","journal-title":"Clin Biochem."},{"key":"2023020108373262500_CIT0021","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/cas.13329","article-title":"Overexpression of leucine-rich \u03b12-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer","volume":"108","author":"Yamamoto","year":"2017","journal-title":"Cancer Sci."},{"key":"2023020108373262500_CIT0022","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-018-4252-6","article-title":"Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker","volume":"18","author":"Shinozaki","year":"2018","journal-title":"BMC Cancer"},{"key":"2023020108373262500_CIT0023","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1038\/s41598-021-90441-x","article-title":"Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease","volume":"11","author":"Yasutomi","year":"2021","journal-title":"Sci Rep."},{"key":"2023020108373262500_CIT0024","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ecco-jcc\/jjw132","article-title":"Leucine-rich alpha-2 glycoprotein is a serum biomarker of mucosal healing in ulcerative colitis","volume":"11","author":"Shinzaki","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2023020108373262500_CIT0025","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","article-title":"Inflammatory bowel disease (1)","volume":"325","author":"Podolsky","year":"1991","journal-title":"N Engl J Med."},{"key":"2023020108373262500_CIT0026","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJM199110033251406","article-title":"Inflammatory bowel disease (2)","volume":"325","author":"Podolsky","year":"1991","journal-title":"N Engl J Med."},{"key":"2023020108373262500_CIT0027","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"2023020108373262500_CIT0028","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1097\/MIB.0000000000000449","article-title":"Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn\u2019s disease","volume":"21","author":"Takenaka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2023020108373262500_CIT0029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"2023020108373262500_CIT0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/j.gastro.2014.04.008","article-title":"Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn\u2019s disease","volume":"147","author":"Takenaka","year":"2014","journal-title":"Gastroenterology"},{"key":"2023020108373262500_CIT0031","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/00365521.2012.660542","article-title":"Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn\u2019s disease","volume":"47","author":"af Bj\u00f6rkesten","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"2023020108373262500_CIT0032","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/MIB.0000000000000131","article-title":"A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn\u2019s disease: recommendations for clinical trial design","volume":"20","author":"Khanna","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"2023020108373262500_CIT0033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/00365521.2019.1596305","article-title":"Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn\u2019s disease under treatment","volume":"54","author":"Tajra","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"2023020108373262500_CIT0034","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/gutjnl-2015-309903","article-title":"IOIBD technical review on endoscopic indices for Crohn\u2019s disease clinical trials","volume":"65","author":"Vuitton","year":"2016","journal-title":"Gut"},{"key":"2023020108373262500_CIT0035","doi-asserted-by":"crossref","first-page":"8825374","DOI":"10.1155\/2021\/8825374","article-title":"Evaluation of serum leucine-rich alpha-2 glycoprotein as a new inflammatory biomarker of inflammatory bowel disease","volume":"2021","author":"Yoshimura","year":"2021","journal-title":"Mediators Inflamm."},{"key":"2023020108373262500_CIT0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00535-020-01737-0","article-title":"Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn\u2019s disease in clinical remission","volume":"56","author":"Takabayashi","year":"2021","journal-title":"J Gastroenterol."},{"key":"2023020108373262500_CIT0037","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00535-021-01793-0","article-title":"Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study","volume":"56","author":"Shinzaki","year":"2021","journal-title":"J Gastroenterol."},{"key":"2023020108373262500_CIT0038","first-page":"S1542-3565:00700-X","article-title":"Serum leucine-rich alpha-2 glycoprotein; a novel biomarker for small bowel mucosal activity in Crohn\u2019s disease","author":"Kawamoto","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"Suppl 2","key":"2023020108373262500_CIT0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.17.s2.17.x","article-title":"Review article: Crohn\u2019s disease: monitoring disease activity","volume":"17","author":"Sostegni","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"2023020108373262500_CIT0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrgastro.2016.141","article-title":"IBS and IBD - separate entities or on a spectrum?","volume":"13","author":"Spiller","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izac076\/43391659\/izac076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/2\/245\/49005785\/izac076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/2\/245\/49005785\/izac076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T14:52:37Z","timestamp":1675263157000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/29\/2\/245\/6569980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,18]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izac076","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,4,18]]}}}